NM_145868.2:c.1457C>T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_145868.2(ANXA11):c.1457C>T(p.Ser486Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000434 in 1,612,962 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_145868.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152054Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000719 AC: 18AN: 250462Hom.: 0 AF XY: 0.0000517 AC XY: 7AN XY: 135370
GnomAD4 exome AF: 0.0000281 AC: 41AN: 1460908Hom.: 0 Cov.: 32 AF XY: 0.0000234 AC XY: 17AN XY: 726660
GnomAD4 genome AF: 0.000191 AC: 29AN: 152054Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74254
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: ANXA11 c.1457C>T (p.Ser486Leu) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 7.2e-05 in 250462 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in ANXA11 causing ANXA11-Related Disorders, allowing no conclusion about variant significance. To our knowledge, no occurrence of c.1457C>T in individuals affected with ANXA11-Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1366578). Based on the evidence outlined above, the variant was classified as uncertain significance. -
ANXA11-related disorder Uncertain:1
The ANXA11 c.1457C>T variant is predicted to result in the amino acid substitution p.Ser486Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.045% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/10-81917398-G-A). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Inborn genetic diseases Uncertain:1
The c.1457C>T (p.S486L) alteration is located in exon 14 (coding exon 13) of the ANXA11 gene. This alteration results from a C to T substitution at nucleotide position 1457, causing the serine (S) at amino acid position 486 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 486 of the ANXA11 protein (p.Ser486Leu). This variant is present in population databases (rs778082972, gnomAD 0.05%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with ANXA11-related conditions. ClinVar contains an entry for this variant (Variation ID: 1366578). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at